Navigation Links
Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol
Date:2/1/2012

ed patients, positive results at the conclusion of the Extract-1 study, the ability to attain permission and to attract patients outside of India, the company's ability to expand its GMP manufacturing capabilities, the Company's ability to attain clinical collaborations to determine the Hemopurifier's® effect with non-interferon based drug regimens, there is no assurance that FDA will approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies of the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer therapies, the company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.

Contacts:


James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com

Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com

John P. Salvador
Director, Communications
858.459.7800 x307
jps@aethlonmedical.com


'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009
2. Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
3. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
4. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
5. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
6. Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
7. Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
8. Aethlon Medical Reestablishes Biodefense Programs
9. Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships
10. Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
11. Aethlon Medical Names Rod Kenley President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Technology advances have had a profound ... a constantly evolving communication environment, companies need to ... with internal executives. It is challenging, however, to ... and tools that are part of today,s communication ... Best Practices, LLC explores the various internal communication ...
(Date:5/17/2013)... Research explores data on treatments for ... to   be presented Shire plc ... specialty biopharmaceutical company, announces that it will present scientific ... Association (APA) 166th Annual Meeting in San ... represent Shire,s ongoing commitment to the clinical research of ...
(Date:5/17/2013)... Fla. , May 17, 2013 Fuse Science, ... delivery technology company that is developing new, patent-pending technologies poised ... announced today that it will hold a business update teleconference ... May 22 nd , 2013 at 4:30 PM ET. ... will host the call and will be joined ...
Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2
... , , ST. LOUIS, Jan. 7 ... Inc., the inspector of elections retained by the Company, has ... stockholders received by the Company on December 22, 2009 (the ... certain stockholders (the "Director Changes") are sufficient to approve the ...
... , , LOS ANGELES , ... Haiti on Tuesday, 4 Survival To Go , an emergency preparedness ... legend Alonzo Mourning to help provide aid to the impoverished nation ...  Until the end of February, 4 Survival To Go will donate ...
Cached Medicine Technology:KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 2KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 3KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 4KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 5KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 6KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 7Help the Haitian Community and Prepare for an Unexpected Disaster 2Help the Haitian Community and Prepare for an Unexpected Disaster 3Help the Haitian Community and Prepare for an Unexpected Disaster 4
(Date:5/19/2013)... Springs, FL (PRWEB) May 19, 2013 Omaha, ... It is also a city with one of the lowest ... ranking it eleventh in their Best Places for Business and ... for Relocation lists. Omaha is centrally located in the ... stalwarts of industry located there. The producers of Editions ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Actos ... federal litigation now underway in U.S. District Court, Western ... Order dated May 3rd, the Court has modified the ... to eight cases rather than four. The next Status ... Thursday, May 23rd. (In re: Actos Product Liability Litigation, ...
(Date:5/19/2013)... California (PRWEB) May 19, 2013 Grinding ... than just losing sleep, or annoying your spouse. At ... report by CNY Central (“Snoring and Teeth Grinding Could ... type of teeth grinding can be hard to prevent. ... million Americans, and one of its symptoms is a ...
(Date:5/19/2013)... 19, 2013 These molecular diagnostics ... UK, Spain, Japan, Italy, Germany and France:, ... diagnostics laboratory practice, as well as key economic, ... market impact during the next five years. , ... biochip technologies, test formats, detection methodologies, trends in ...
(Date:5/19/2013)... York, New York (PRWEB) May 19, 2013 ... that a Case Management Conference was recently convened for ... a federal multidistrict litigation now underway in U.S. District ... posted on the Court’s website on May 14th, the ... It was also reported during the Conference that ...
Breaking Medicine News(10 mins):Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... have lower risks of Alzheimer,s disease and other cognitive ... In more than half of the studies, published since ... had lower dementia risks than nondrinkers. In only a ... a two-edged sword," said Michael Collins, Ph.D., a professor ...
... Review Examines All Aspects of Hospital OperationsCAMBRIDGE, Mass., ... survey of Cambridge Health Alliance by The Joint ... safety and quality of health care in the ... CHA,s chief executive officer, and "is the best ...
... bid to force TomoTherapy to consider strategic alternativesMADISON, Wis., Dec. ... Capital Group, announced that on December 23, 2008 it nominated ... Inc. (Nasdaq: TOMO ). This step is the ... for the company,s shareholders in the wake of the precipitous ...
... Mich., Dec. 29 Versus Technology,Inc. ("Versus" or ... year ended Oct. 31, 2008, compared to revenues ... the fiscal quarter ended Oct. 31, 2008, were,$1,748,000 ... period in 2007.,Versus, quarterly revenues can vary significantly ...
... Hebrew University of Jerusalem have succeeded in reversing brain birth ... brain cells. , The work of Prof. Joseph Yanai ... presented at the Tel Aviv Stem Cells Conference last spring ... at the seventh annual meeting of the International Society ...
... 29 After retiring from a night-shift job 12 years ... on TV shows, including Monday Night Football. He also ate ... caught up with him: He became overweight and was diagnosed ... when he knew he had to change his lifestyle."It was ...
Cached Medicine News:Health News:Moderate drinking can reduce risks of Alzheimer's dementia and cognitive decline 2Health News:Joint Commission Reports Positive Survey Results for CHA 2Health News:Joint Commission Reports Positive Survey Results for CHA 3Health News:Avalon Portfolio Nominates Slate of Directors for TomoTherapy Board 2Health News:Avalon Portfolio Nominates Slate of Directors for TomoTherapy Board 3Health News:Versus Technology Announces Fiscal Year Results 2Health News:Versus Technology Announces Fiscal Year Results 3Health News:Versus Technology Announces Fiscal Year Results 4Health News:Versus Technology Announces Fiscal Year Results 5Health News:Versus Technology Announces Fiscal Year Results 6Health News:Versus Technology Announces Fiscal Year Results 7Health News:Hebrew University scientists succeed through stem cell therapy in reversing brain birth defects 2Health News:African Americans to Reach Health Resolutions Through Search Your Heart 2
Fine pointed grooved jaws with smooth curve from tip to finger grip style handle. Dull finish....
Inner jaw space 2.0 mm - 45 degree tip angulation. 20 gauge (.89 mm) diameter shaft and stationary distal jaw. Lightweight squeeze handle with dull finish. Jaws 1.5 mm serrated....
Straight shafts with 5.5 mm tying platform and 45 degree 0.3 mm teeth. Wide serrated handle with polished finish....
Straight shafts with 1 x 2 teeth. Flat handle with polished finish....
Medicine Products: